In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...

Sycamore Partners has been speaking with private credit firms about debt financing for a potential deal, despite an earlier report that takeover talks had stalled.

Pharmacists in the Four-States say their livelihoods are at risk as major companies gain more control of the drug market. They're warning that Pharmacy Benefit Mangers, better known as PBMs, have an ...

Independent pharmacies across Kansas will close on Wednesday, Feb.5, for a day of advocacy to raise awareness of what they ...

As national testing again ranks Oklahoma in the bottom 10 for academic results, lawmakers on Wednesday debated whether the state is headed in the right direction or ...